Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 42, No. 3, 2009
Issue release date: November 2009
Section title: Short Communication
Free Access
Ophthalmic Res 2009;42:141–146

Development of a Streptococcus pneumoniae Keratitis Model in Mice

Moore III Q.C.a · McCormick C.C.a · Norcross E.W.a · Onwubiko C.a · Sanders M.E.a · Fratkin J.b · McDaniel L.S.a · O’Callaghan R.J.a · Marquart M.E.a
Departments of aMicrobiology and bPathology, University of Mississippi Medical Center, Jackson, Miss., USA
email Corresponding Author

Mary E. Marquart, PhD

Department of Microbiology

University of Mississippi Medical Center, 2500 North State Street

Jackson, MS 39216 (USA)

Tel. +1 601 815 6934, Fax +1 601 984 1708, E-Mail Mmarquart@microbio.umsmed.edu


  1. Parmar P, Salman A, Kalavathy CM, Jesudasan CA, Thomas PA: Pneumococcal keratitis: a clinical profile. Clin Exp Ophthalmol 2003;31:44–47.
  2. Bhave P, Chamie G: Streptococcus pneumoniae keratitis. J Hosp Med 2008;3:353.
  3. Wagoner MD, Al-Ghamdi AH, Al-Rajhi AA: Bacterial keratitis after primary pediatric penetrating keratoplasty. Am J Ophthalmol 2007;143:1045–1047.
  4. Hooi SH, Hooi ST: Culture-proven bacterial keratitis in a Malaysian general hospital. Med J Malaysia 2005;60:614–623.
  5. Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y: Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 2001;85:842–847.
  6. Asbell P, Stenson S: Ulcerative keratitis: survey of 30 years’ laboratory experience. Arch Ophthalmol 1982;100:77–80.
  7. Dunlop AA, Wright ED, Howlader SA, Nazrul I, Husain R, McClellan K, Billson FA: Suppurative corneal ulceration in Bangladesh: a study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust NZ J Ophthalmol 1994;22:105–110.
  8. Dada T, Sharma N, Dada VK, Vajpayee RB: Pneumococcal keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2000;26:460–461.
  9. Kunimoto DY, Sharma S, Reddy MK, Gopinathan U, Jyothi J, Miller D, Rao GN: Microbial keratitis in children. Ophthalmology 1998;105:252–257.
  10. Green MD, Apel AJ, Naduvilath T, Stapleton FJ: Clinical outcomes of keratitis. Clin Exp Ophthalmol 2007;35:421–426.
  11. Liesgang TJ: Bacterial and fungal keratitis; in Kaufman HE, Barron BA, McDonald MB (eds): The Cornea. Boston, Butterworth-Heinemann, 1998, pp 159–219.
  12. Callegan MC, O’Callaghan RJ, Hill JM: Pharmacokinetic considerations in the treatment of bacterial keratitis. Clin Pharmacokinet 1994;27:129–149.
  13. Liesgang TJ: Bacterial and fungal keratitis; in Kaufman HE, et al (eds): The Cornea. New York, Churchill Livingstone, 1988, pp 217–270.
  14. Johnson MK, Hobden JA, Hagenah M, O’Callaghan RJ, Hill JM, Chen S: The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res 1990;9:1107–1114.
  15. Harrison JC, Karcioglu ZA, Johnson MK: Response of leukopenic rabbits to pneumococcal toxin. Curr Eye Res 1982;2:705–710.
  16. Johnson MK, Callegan MC, Engel LS, O’Callaghan RJ, Hill JM, Hobden JA, Boulnois GJ, Andrew PW, Mitchell TJ: Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea. Curr Eye Res 1995;14:281–284.
  17. Green SN, Sanders M, Moore QC III, Norcross EW, Monds KS, Caballero AR, Mc- Daniel LS, Robinson SA, Onwubiko C, O’Callaghan RJ, Marquart ME: Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum. Invest Ophthalmol Vis Sci 2008;49:290–294.
  18. Marquart ME, Monds KS, McCormick CC, Dixon SN, Sanders ME, Reed JM, McDaniel LS, Caballero AR, O’Callaghan RJ: Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea. Invest Ophthalmol Vis Sci 2007;48:2661–2666.
  19. Reed JM, O’Callaghan RJ, Girgis DO, McCormick CC, Caballero AR, Marquart ME: Ocular virulence of capsule-deficient Streptococcus pneumoniae in a rabbit keratitis model. Invest Ophthalmol Vis Sci 2005;46:604–608.
  20. Girgis DO, Sloop GD, Reed JM, O’Callaghan RJ: A new topical model of Staphylococcus corneal infection in the mouse. Invest Ophthalmol Vis Sci 2003;44:1591–1597.
  21. Hume EB, Cole N, Khan S, Garthwaite LL, Aliwarga Y, Schubert TL, Willcox MD: A Staphylococcus aureus mouse keratitis topical infection model: cytokine balance in different strains of mice. Immunol Cell Biol 2005;83:294–300.
  22. Sun Y, Hise AG, Kalsow CM, Pearlman E: Staphylococcus aureus-induced corneal inflammation is dependent on Toll-like receptor 2 and myeloid differentiation factor 88. Infect Immun 2006;74:5325–5332.
  23. Hazlett LD: Role of innate and adaptive immunity in the pathogenesis of keratitis. Ocul Immunol Inflamm 2005;13:133–138.
  24. Koch AL: Autolysis control hypotheses for tolerance to wall antibiotics. Antimicrob Agents Chemother 2001;45:2671–2675.
  25. Hazlett LD: Inflammatory response to Pseudomonas aeruginosa keratitis. Ocul Surf 2005;3:S139–S141.
  26. Hazlett LD: Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res 2004;23:1–30.
  27. Huang X, Hazlett LD, Du W, Barrett RP: SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling. J Immunol 2006;177:548–556.
  28. Girgis DO, Sloop GD, Reed JM, O’Callaghan RJ: Effects of toxin production in a murine model of Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci 2005;46:2064–2070.
  29. Hume EB, Cole N, Garthwaite LL, Khan S, Willcox MD: A protective role for IL-6 in staphylococcal microbial keratitis. Invest Ophthalmol Vis Sci 2006;47:4926–4930.